Pistes urgentes dans le traitement de l’infection par le COVID-19 : cibler l’inflammation en aval pour prévenir un syndrome catastrophique

[Article in French]

Luca Quartuccio¹, Luca Semerano^{2

3

4}, Maurizio Benucci⁵, Marie-Christophe Boissier^{2

3

4}, Salvatore De Vita¹

Affiliations

¹ Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, University of Udine, Udine, Italy.
² Université Sorbonne Paris Nord, Li2P, Bobigny, France.
³ Inserm U1125, Bobigny, France.
⁴ Assistance Publique-Hôpitaux de Paris, GH HUPSSD, Rheumatology Department, Bobigny, France.
⁵ Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy.

Editorial

[Article in French]

Luca Quartuccio et al. Rev Rhum Ed Fr. 2020 May.

. 2020 May;87(3):146-149.

doi: 10.1016/j.rhum.2020.03.009. Epub 2020 Apr 24.

Luca Quartuccio¹, Luca Semerano^{2

3

4}, Maurizio Benucci⁵, Marie-Christophe Boissier^{2

3

4}, Salvatore De Vita¹

¹ Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, University of Udine, Udine, Italy.
² Université Sorbonne Paris Nord, Li2P, Bobigny, France.
³ Inserm U1125, Bobigny, France.
⁴ Assistance Publique-Hôpitaux de Paris, GH HUPSSD, Rheumatology Department, Bobigny, France.
⁵ Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy.

No abstract available

Comment on

Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome.
Quartuccio L, Semerano L, Benucci M, Boissier MC, De Vita S. Quartuccio L, et al. Joint Bone Spine. 2020 May;87(3):191-193. doi: 10.1016/j.jbspin.2020.03.011. Joint Bone Spine. 2020. PMID: 32321634 Free PMC article. No abstract available.

1. Lai C.C., Wang C.Y., Wang Y.H. Global epidemiology of coronavirus disease 2019: disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Int J Antimicrob Agents. 2020:105946. doi: 10.1016/j.ijantimicag.2020.105946. - DOI - PMC - PubMed
1. Yuen K.S., Ye Z.W., Fung S.Y. SARS-CoV-2 and COVID-19: The most important research questions. Cell Biosci. 2020;10:40. - PMC - PubMed
1. Zhou D., Dai S.M., Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother. 2020 doi: 10.1093/jac/dkaa114. - DOI - PMC - PubMed
1. Conti P., Ronconi G., Caraffa A. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020 doi: 10.23812/CONTI-E. - DOI - PubMed
1. De Vita S., Quartuccio L., Isola M. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum. 2012;64:843–853. - PubMed